Ocular Therapeutix, Inc. (OCUL) Shareholders’ equity 2016–2025
Ocular Therapeutix, Inc. (OCUL) shareholders’ equity at each fiscal year-end, per SEC filings.
$654.3MFY2025 · since FY2016: $52.0M → $654.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $654.3M | +107.5% |
| FY2024 | $315.3M | +246.0% |
| FY2023 | $91.1M | +157.6% |
| FY2022 | $35.4M | -59.8% |
| FY2021 | $88.0M | +15.6% |
| FY2020 | $76.1M | +2196.3% |
| FY2019 | -$3.6M | -110.1% |
| FY2018 | $35.9M | +37.2% |
| FY2017 | $26.1M | -49.7% |
| FY2016 | $52.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice